Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration
An engineered patch of retinal pigment epithelium generated from human embryonic stem cells is transplanted into the eyes of two patients. Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progr...
Saved in:
Published in | Nature biotechnology Vol. 36; no. 4; pp. 328 - 337 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.04.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | An engineered patch of retinal pigment epithelium generated from human embryonic stem cells is transplanted into the eyes of two patients.
Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)–derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD. |
---|---|
AbstractList | Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)-derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD. An engineered patch of retinal pigment epithelium generated from human embryonic stem cells is transplanted into the eyes of two patients. Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)–derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD. Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)-derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD.Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic stem cell (hESC)-derived RPE monolayer on a coated, synthetic basement membrane. We delivered the patch, using a purpose-designed microsurgical tool, into the subretinal space of one eye in each of two patients with severe exudative AMD. Primary endpoints were incidence and severity of adverse events and proportion of subjects with improved best-corrected visual acuity of 15 letters or more. We report successful delivery and survival of the RPE patch by biomicroscopy and optical coherence tomography, and a visual acuity gain of 29 and 21 letters in the two patients, respectively, over 12 months. Only local immunosuppression was used long-term. We also present the preclinical surgical, cell safety and tumorigenicity studies leading to trial approval. This work supports the feasibility and safety of hESC-RPE patch transplantation as a regenerative strategy for AMD. |
Audience | Academic |
Author | Fynes, Kate Hasan, Shazeen M Vugler, Anthony da Cruz, Lyndon Tufail, Adnan Georgiadis, Odysseas Kerby, Julie Feng, Gang Fenster, Mike Daniels, Julie T Luo, Yvonne H Nommiste, Britta Sagoo, Mandeep S Whiting, Paul Gooljar, Sakina B Whitlock, Mark Wilbrey, Anna Harbinson, Tricia Holder, Graham E Loudon, Peter T Coffey, Peter J Carr, Amanda-Jayne F Ramsden, Conor M Steer, Juliette Vernon, Amanda Robson, Anthony G Ahmado, Ahmad Bictash, Magda |
Author_xml | – sequence: 1 givenname: Lyndon surname: da Cruz fullname: da Cruz, Lyndon email: Lyndon.dacruz@Moorfields.nhs.uk organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL), NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, Wellcome/EPSRC Centre for Interventional & Surgical Sciences (WEISS), Charles Bell House – sequence: 2 givenname: Kate surname: Fynes fullname: Fynes, Kate organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 3 givenname: Odysseas surname: Georgiadis fullname: Georgiadis, Odysseas organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL), NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 4 givenname: Julie surname: Kerby fullname: Kerby, Julie organization: Pfizer, Granta Park, Cell and Gene Therapy Catapult – sequence: 5 givenname: Yvonne H surname: Luo fullname: Luo, Yvonne H organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL), NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 6 givenname: Ahmad surname: Ahmado fullname: Ahmado, Ahmad organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 7 givenname: Amanda surname: Vernon fullname: Vernon, Amanda organization: Cells for Sight, Transplantation & Research Program, UCL Institute of Ophthalmology – sequence: 8 givenname: Julie T surname: Daniels fullname: Daniels, Julie T organization: Cells for Sight, Transplantation & Research Program, UCL Institute of Ophthalmology – sequence: 9 givenname: Britta surname: Nommiste fullname: Nommiste, Britta organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 10 givenname: Shazeen M surname: Hasan fullname: Hasan, Shazeen M organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 11 givenname: Sakina B surname: Gooljar fullname: Gooljar, Sakina B organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 12 givenname: Amanda-Jayne F orcidid: 0000-0002-5469-0030 surname: Carr fullname: Carr, Amanda-Jayne F organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 13 givenname: Anthony surname: Vugler fullname: Vugler, Anthony organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL) – sequence: 14 givenname: Conor M surname: Ramsden fullname: Ramsden, Conor M organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL), Moorfields Eye Hospital NHS Foundation Trust – sequence: 15 givenname: Magda surname: Bictash fullname: Bictash, Magda organization: Pfizer, Granta Park – sequence: 16 givenname: Mike surname: Fenster fullname: Fenster, Mike organization: Pfizer, Granta Park – sequence: 17 givenname: Juliette surname: Steer fullname: Steer, Juliette organization: Pfizer, Granta Park – sequence: 18 givenname: Tricia surname: Harbinson fullname: Harbinson, Tricia organization: Pfizer, Granta Park – sequence: 19 givenname: Anna surname: Wilbrey fullname: Wilbrey, Anna organization: Pfizer, Granta Park – sequence: 20 givenname: Adnan surname: Tufail fullname: Tufail, Adnan organization: NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 21 givenname: Gang surname: Feng fullname: Feng, Gang organization: Pfizer, Granta Park – sequence: 22 givenname: Mark surname: Whitlock fullname: Whitlock, Mark organization: Pfizer, Granta Park – sequence: 23 givenname: Anthony G surname: Robson fullname: Robson, Anthony G organization: NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 24 givenname: Graham E surname: Holder fullname: Holder, Graham E organization: NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 25 givenname: Mandeep S surname: Sagoo fullname: Sagoo, Mandeep S organization: NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust – sequence: 26 givenname: Peter T surname: Loudon fullname: Loudon, Peter T organization: Pfizer, Granta Park – sequence: 27 givenname: Paul surname: Whiting fullname: Whiting, Paul organization: Pfizer, Granta Park, UCL Institute of Neurology, Queen Square – sequence: 28 givenname: Peter J surname: Coffey fullname: Coffey, Peter J organization: The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology, University College London (UCL), NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Center for Stem Cell Biology and Engineering, NRI, UC |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29553577$$D View this record in MEDLINE/PubMed |
BookMark | eNqNktuK1TAUhouMOAcFn0AC3ijYbdKmSXs5DB4GBkY83YbVdLU7Q5vWJBX3lb6Db-iTmDp73G6dCwkkYfH9C_71r-PkwI4Wk-QhoytG8_K5rcOKM8bvJEes4CJlohIH8U9LmVJWiMPk2PsrSqngQtxLDrOqKPJCyqPk65s1eCSM6N5Yo6EnPszNhowtAUtwqN1mjPVYxYFo7Psf37436MxnbIjDYGxUTKYb0AaCkwlr7M08kAmCXhNjCXSYOuwhRH4APffgSIMdWnQQzGjvJ3db6D0-2L4nyYeXL96fvU4vLl-dn51epLoo85ACy2WGJXAEKeu6actMSC2yNi8ZF5TnnGYllVUDiFwKDZwCazTHvKi10EV-kjy57ju58dOMPqjB-MUPWBxnr7I4Js4or2hEH_-FXo2zi0YXKmNSVCWXO6qDHpWx7Rgc6KWpOi3ynPOCZjxSq1uoeBocjI4htibW9wRP9wSRCfgldDB7r87fvf1_9vLjPvvsD7aevbHo4-VNtw7-WrKHP9rOYK4HbNTkzABuo24WZ2dMu9F7h63SJvxKNBo0vWJULZup4maqZTN3AfwW3PS8Bd368hGxHbpdAP-wPwGUKO7O |
CitedBy_id | crossref_primary_10_1056_NEJMra1716145 crossref_primary_10_1038_s41598_022_10540_1 crossref_primary_10_2139_ssrn_4093938 crossref_primary_10_1007_s13770_023_00555_8 crossref_primary_10_3389_fbioe_2020_00456 crossref_primary_10_3389_fnmol_2022_1068185 crossref_primary_10_1038_s41598_023_37235_5 crossref_primary_10_1016_j_ceb_2018_05_006 crossref_primary_10_1016_j_jcyt_2024_01_014 crossref_primary_10_2174_011574888X255496230923164547 crossref_primary_10_1371_journal_pone_0201683 crossref_primary_10_3390_biomedicines10030669 crossref_primary_10_1007_s12015_021_10312_w crossref_primary_10_1016_j_stem_2019_10_001 crossref_primary_10_1002_ctm2_95 crossref_primary_10_1016_j_stemcr_2020_12_007 crossref_primary_10_3389_fcell_2021_749131 crossref_primary_10_1016_j_exer_2020_108305 crossref_primary_10_1016_j_preteyeres_2018_09_002 crossref_primary_10_1016_j_mtbio_2022_100253 crossref_primary_10_1177_08839115241278739 crossref_primary_10_1016_j_cobme_2022_100390 crossref_primary_10_1016_j_stem_2023_03_017 crossref_primary_10_1111_cpr_13203 crossref_primary_10_1016_j_stemcr_2023_10_008 crossref_primary_10_1186_s13287_024_04052_0 crossref_primary_10_1016_j_tibtech_2022_11_008 crossref_primary_10_1038_s41598_022_07622_5 crossref_primary_10_1089_scd_2018_0076 crossref_primary_10_1126_scitranslmed_aat5580 crossref_primary_10_3390_bioengineering9110669 crossref_primary_10_4103_ijo_IJO_82_22 crossref_primary_10_1038_s41587_024_02196_1 crossref_primary_10_1002_adfm_202002931 crossref_primary_10_1016_j_preteyeres_2022_101065 crossref_primary_10_1038_s41580_020_00292_z crossref_primary_10_1167_iovs_61_4_5 crossref_primary_10_3390_ijms21228484 crossref_primary_10_1016_j_mcn_2020_103523 crossref_primary_10_1371_journal_pgen_1007939 crossref_primary_10_4103_1673_5374_243711 crossref_primary_10_1002_sctm_18_0026 crossref_primary_10_1007_s00401_018_1941_9 crossref_primary_10_3390_cells12050773 crossref_primary_10_1016_j_gendis_2020_11_020 crossref_primary_10_1093_stcltm_szac001 crossref_primary_10_1016_j_survophthal_2024_08_002 crossref_primary_10_1016_j_jphotobiol_2023_112654 crossref_primary_10_1007_s12015_024_10717_3 crossref_primary_10_1016_j_reth_2024_09_001 crossref_primary_10_1146_annurev_genom_083118_015043 crossref_primary_10_3389_fcvm_2020_610364 crossref_primary_10_1007_s10439_019_02393_z crossref_primary_10_1016_j_bioactmat_2022_01_011 crossref_primary_10_1038_s41421_018_0053_y crossref_primary_10_3389_fbioe_2020_00534 crossref_primary_10_1038_s41551_021_00836_4 crossref_primary_10_1080_02713683_2020_1722180 crossref_primary_10_1038_s41419_020_02955_3 crossref_primary_10_1007_s11548_022_02603_5 crossref_primary_10_1016_j_drudis_2020_09_034 crossref_primary_10_1097_IAE_0000000000002449 crossref_primary_10_1364_BOE_472274 crossref_primary_10_3390_ijms23158529 crossref_primary_10_1038_s41598_023_42236_5 crossref_primary_10_1172_JCI131187 crossref_primary_10_1016_j_preteyeres_2021_100950 crossref_primary_10_15388_Amed_2021_28_1_7 crossref_primary_10_3390_jcm10081785 crossref_primary_10_1242_bio_060245 crossref_primary_10_3390_jcm8030288 crossref_primary_10_1002_sctm_18_0282 crossref_primary_10_1186_s13287_022_02712_7 crossref_primary_10_1002_eer3_2 crossref_primary_10_1002_eer3_4 crossref_primary_10_2174_1566523221666210707123809 crossref_primary_10_3390_ijms23169049 crossref_primary_10_1007_s00347_022_01631_5 crossref_primary_10_1101_cshperspect_a035683 crossref_primary_10_1146_annurev_pharmtox_010919_023245 crossref_primary_10_1089_jop_2019_0039 crossref_primary_10_1089_jop_2024_0130 crossref_primary_10_1002_cpsc_98 crossref_primary_10_3389_fbioe_2020_588014 crossref_primary_10_1016_j_preteyeres_2019_03_001 crossref_primary_10_1038_s41419_022_05199_5 crossref_primary_10_1093_hropen_hoy024 crossref_primary_10_1016_j_ajo_2019_04_033 crossref_primary_10_1155_2018_5056279 crossref_primary_10_1016_j_omtm_2019_10_013 crossref_primary_10_1080_02713683_2019_1691237 crossref_primary_10_3390_jcm9082675 crossref_primary_10_1016_j_scr_2019_101514 crossref_primary_10_1186_s12938_018_0535_z crossref_primary_10_1097_ICU_0000000000001034 crossref_primary_10_1002_sctm_19_0396 crossref_primary_10_1186_s12967_024_05016_x crossref_primary_10_1360_SSV_2021_0075 crossref_primary_10_3389_fmed_2022_949543 crossref_primary_10_3390_app11052154 crossref_primary_10_1016_j_neurobiolaging_2024_04_012 crossref_primary_10_17116_oftalma2019135052226 crossref_primary_10_1186_s13287_022_03141_2 crossref_primary_10_4103_singaporemedj_SMJ_2022_179 crossref_primary_10_3389_frtra_2023_1130086 crossref_primary_10_1016_j_molimm_2019_11_007 crossref_primary_10_3389_fnins_2020_00838 crossref_primary_10_1038_s41582_018_0007_x crossref_primary_10_1111_dgd_12704 crossref_primary_10_1007_s00417_023_06014_3 crossref_primary_10_1084_jem_20230913 crossref_primary_10_1109_TRO_2023_3275381 crossref_primary_10_1016_j_cellin_2024_100223 crossref_primary_10_1016_j_cobme_2024_100538 crossref_primary_10_1038_d41586_019_01107_8 crossref_primary_10_3389_fbioe_2022_905516 crossref_primary_10_3389_fcell_2023_1098406 crossref_primary_10_1007_s40135_021_00275_z crossref_primary_10_1016_j_ebiom_2021_103360 crossref_primary_10_3389_fncel_2020_00171 crossref_primary_10_1016_j_stemcr_2025_102424 crossref_primary_10_3390_ijms23158722 crossref_primary_10_37039_1982_8551_20210038 crossref_primary_10_1016_j_exer_2021_108448 crossref_primary_10_1016_j_stemcr_2025_102425 crossref_primary_10_1089_scd_2021_0266 crossref_primary_10_1016_j_xops_2025_100770 crossref_primary_10_5500_wjt_v14_i4_97690 crossref_primary_10_1016_j_jconrel_2023_08_041 crossref_primary_10_1007_s12015_024_10740_4 crossref_primary_10_3390_ijms222111317 crossref_primary_10_1007_s13346_022_01231_5 crossref_primary_10_3389_fmed_2021_686774 crossref_primary_10_1016_j_stemcr_2020_06_019 crossref_primary_10_3389_fcell_2021_741368 crossref_primary_10_1016_j_preteyeres_2018_11_003 crossref_primary_10_1186_s13023_021_01843_z crossref_primary_10_4103_1673_5374_300329 crossref_primary_10_1186_s13287_021_02395_6 crossref_primary_10_1186_s13287_022_02809_z crossref_primary_10_3390_biomedicines10020208 crossref_primary_10_1016_j_stemcr_2023_01_007 crossref_primary_10_1016_j_preteyeres_2018_11_001 crossref_primary_10_7759_cureus_40527 crossref_primary_10_1038_s41598_021_85631_6 crossref_primary_10_1016_j_drudis_2023_103676 crossref_primary_10_1097_IAE_0000000000002429 crossref_primary_10_3390_cells8121523 crossref_primary_10_1039_D2BM01413K crossref_primary_10_12688_f1000research_19598_3 crossref_primary_10_1016_j_biomaterials_2019_119603 crossref_primary_10_1186_s13287_024_04007_5 crossref_primary_10_12688_f1000research_19598_4 crossref_primary_10_12688_f1000research_19598_5 crossref_primary_10_1016_j_ejpb_2023_01_026 crossref_primary_10_1016_j_visres_2023_108315 crossref_primary_10_1016_j_actbio_2022_07_064 crossref_primary_10_3390_pharmaceutics16081076 crossref_primary_10_1007_s11427_020_1836_7 crossref_primary_10_1007_s10792_025_03493_7 crossref_primary_10_1109_TBME_2020_2996013 crossref_primary_10_12688_f1000research_19598_1 crossref_primary_10_12688_f1000research_19598_2 crossref_primary_10_1186_s13287_020_1568_3 crossref_primary_10_1039_D2TB02601E crossref_primary_10_1038_s41536_019_0081_8 crossref_primary_10_1167_tvst_11_4_24 crossref_primary_10_3390_medicina57010064 crossref_primary_10_5812_jjcmb_136652 crossref_primary_10_3389_fcell_2022_813538 crossref_primary_10_1016_j_oret_2022_04_009 crossref_primary_10_1073_pnas_2214842120 crossref_primary_10_1038_s41551_022_00987_y crossref_primary_10_1093_stcltm_szad028 crossref_primary_10_1177_0192623320918241 crossref_primary_10_1167_tvst_10_1_10 crossref_primary_10_1111_jcmm_16882 crossref_primary_10_1007_s10561_020_09826_3 crossref_primary_10_1016_S0140_6736_22_02609_5 crossref_primary_10_3390_ijms222212298 crossref_primary_10_1016_j_apmt_2025_102602 crossref_primary_10_1016_j_heares_2018_06_018 crossref_primary_10_1038_s41392_020_0122_1 crossref_primary_10_1016_j_stem_2024_12_005 crossref_primary_10_1089_ten_tea_2019_0007 crossref_primary_10_1002_ctm2_1646 crossref_primary_10_1016_j_exer_2021_108882 crossref_primary_10_1038_s41392_022_01251_0 crossref_primary_10_1007_s00417_024_06463_4 crossref_primary_10_1101_cshperspect_a041295 crossref_primary_10_1126_scitranslmed_aaz2253 crossref_primary_10_3390_diagnostics14101005 crossref_primary_10_1093_stcltm_szad039 crossref_primary_10_1155_2020_5690252 crossref_primary_10_1016_j_addr_2023_114870 crossref_primary_10_1016_j_arr_2024_102322 crossref_primary_10_1016_j_preteyeres_2019_06_002 crossref_primary_10_1097_WNO_0000000000001375 crossref_primary_10_1002_adma_202404428 crossref_primary_10_1088_1741_2552_ad31c4 crossref_primary_10_3390_ijms21197279 crossref_primary_10_3390_ijms19082325 crossref_primary_10_3390_cells13181549 crossref_primary_10_1007_s40883_020_00190_y crossref_primary_10_1016_j_stemcr_2022_01_001 crossref_primary_10_1515_jpm_2022_0510 crossref_primary_10_1002_sctm_18_0210 crossref_primary_10_1038_s41433_019_0348_8 crossref_primary_10_1167_tvst_7_4_6 crossref_primary_10_1093_stcltm_szac029 crossref_primary_10_1021_acsami_8b10513 crossref_primary_10_3389_fceng_2022_832754 crossref_primary_10_1002_med_21922 crossref_primary_10_1089_scd_2019_0090 crossref_primary_10_3390_ijms222111542 crossref_primary_10_1007_s13238_018_0606_8 crossref_primary_10_3390_ijms232213794 crossref_primary_10_1016_j_bioactmat_2023_08_003 crossref_primary_10_2147_BTT_S290331 crossref_primary_10_1136_bmjophth_2022_000981 crossref_primary_10_1016_j_stem_2018_05_013 crossref_primary_10_1021_acs_chemrev_0c00342 crossref_primary_10_1016_j_preteyeres_2018_10_006 crossref_primary_10_3390_ijms231911482 crossref_primary_10_1007_s12015_024_10689_4 crossref_primary_10_3389_fimmu_2021_621007 crossref_primary_10_2174_1574888X18666230417084518 crossref_primary_10_3390_brainsci12121620 crossref_primary_10_1089_ten_teb_2022_0190 crossref_primary_10_1016_j_imu_2019_100270 crossref_primary_10_1007_s12015_021_10262_3 crossref_primary_10_1101_cshperspect_a041308 crossref_primary_10_1101_cshperspect_a041309 crossref_primary_10_3390_life12121998 crossref_primary_10_1016_j_tcb_2019_10_001 crossref_primary_10_1159_000544702 crossref_primary_10_3389_fcell_2023_1157893 crossref_primary_10_1186_s13287_020_01608_8 crossref_primary_10_1038_s41598_019_45416_4 crossref_primary_10_1016_j_ophtha_2019_03_019 crossref_primary_10_1016_j_brainresbull_2019_03_005 crossref_primary_10_1016_j_bioactmat_2023_07_019 crossref_primary_10_1016_j_isci_2022_105050 crossref_primary_10_1016_j_eclinm_2022_101604 crossref_primary_10_1093_jleuko_qiac016 crossref_primary_10_1016_j_jnrt_2022_100015 crossref_primary_10_1016_j_ydbio_2022_06_006 crossref_primary_10_3389_fbioe_2023_1199922 crossref_primary_10_1111_aor_14241 crossref_primary_10_1080_17469899_2023_2296895 crossref_primary_10_1088_1741_2552_aca69d crossref_primary_10_1155_2019_4568979 crossref_primary_10_1186_s13287_021_02316_7 crossref_primary_10_3390_ijms221910594 crossref_primary_10_1016_j_oret_2019_09_017 crossref_primary_10_1159_000517794 crossref_primary_10_3390_cells10020240 crossref_primary_10_1016_j_addr_2025_115525 crossref_primary_10_1167_tvst_9_7_5 crossref_primary_10_1007_s12264_024_01189_z crossref_primary_10_1016_j_tibs_2021_04_006 crossref_primary_10_1146_annurev_vision_120222_012817 crossref_primary_10_1167_iovs_18_26222 crossref_primary_10_3390_ijms232112982 crossref_primary_10_1080_17469899_2019_1568872 crossref_primary_10_1016_j_reth_2024_05_018 crossref_primary_10_31348_2019_6_1 crossref_primary_10_18502_jovr_v17i4_12325 crossref_primary_10_3390_ijms25158060 crossref_primary_10_1016_j_kint_2019_04_040 crossref_primary_10_1177_2515841418817501 crossref_primary_10_3390_cells13020179 crossref_primary_10_1016_j_imbio_2022_152211 crossref_primary_10_1007_s10439_021_02756_5 crossref_primary_10_1177_09636897221104451 crossref_primary_10_1186_s13287_021_02546_9 crossref_primary_10_4103_IJO_IJO_2491_23 crossref_primary_10_1097_APO_0000000000000362 crossref_primary_10_1016_j_reth_2023_03_004 crossref_primary_10_5124_jkma_2018_61_7_416 crossref_primary_10_3390_cells11131984 crossref_primary_10_1089_ten_tec_2020_0072 crossref_primary_10_1016_j_heliyon_2023_e18228 crossref_primary_10_1186_s13287_022_02894_0 crossref_primary_10_1167_iovs_65_4_32 crossref_primary_10_1371_journal_pone_0304073 crossref_primary_10_1038_s43856_024_00617_5 crossref_primary_10_3390_ijms21176066 crossref_primary_10_1016_j_stemcr_2021_02_021 crossref_primary_10_3389_fnins_2018_00651 crossref_primary_10_1021_acsbiomaterials_9b01189 crossref_primary_10_3390_medicina58010102 crossref_primary_10_1016_j_stemcr_2019_04_015 crossref_primary_10_2147_BTT_S252581 crossref_primary_10_1097_ICU_0000000000000838 crossref_primary_10_1002_advs_202302940 crossref_primary_10_1038_s41573_022_00476_6 crossref_primary_10_3390_life14060668 crossref_primary_10_1111_cpr_13813 crossref_primary_10_1177_09636897221085901 crossref_primary_10_1038_s41598_020_70979_y crossref_primary_10_1186_s12967_023_03937_7 crossref_primary_10_1111_ceo_14128 crossref_primary_10_1016_j_reth_2024_04_008 crossref_primary_10_1186_s13287_018_1036_5 crossref_primary_10_1111_bph_15459 crossref_primary_10_1167_tvst_10_10_10 crossref_primary_10_3390_cells11233755 crossref_primary_10_1167_tvst_10_10_13 crossref_primary_10_1038_nbt_4118 crossref_primary_10_2174_1574888X18666230313094121 crossref_primary_10_1016_j_preteyeres_2019_100803 crossref_primary_10_1167_tvst_10_10_17 crossref_primary_10_1039_D1LC00790D crossref_primary_10_1039_D1TB00976A crossref_primary_10_1038_s41419_022_05433_0 crossref_primary_10_1038_s41598_024_69917_z crossref_primary_10_1042_ETLS20190091 crossref_primary_10_1080_14728214_2021_1931120 crossref_primary_10_3928_23258160_20210927_01 crossref_primary_10_1021_acsabm_0c01130 crossref_primary_10_1016_j_oret_2020_04_017 crossref_primary_10_1111_aos_15034 crossref_primary_10_1089_blr_2024_29337_jc crossref_primary_10_1186_s40662_023_00351_4 crossref_primary_10_1016_S0929_693X_23_00226_9 crossref_primary_10_1038_s41591_018_0110_y crossref_primary_10_1016_j_exer_2020_108283 crossref_primary_10_1111_cpr_12946 crossref_primary_10_1007_s11626_024_00865_8 crossref_primary_10_1089_ten_tea_2023_0290 crossref_primary_10_1167_tvst_12_7_23 crossref_primary_10_3310_hta22270 crossref_primary_10_3390_pr10040678 crossref_primary_10_1097_ICU_0000000000000746 crossref_primary_10_1523_ENEURO_0107_22_2022 crossref_primary_10_2139_ssrn_3571292 crossref_primary_10_1186_s12967_023_04785_1 crossref_primary_10_3390_cells12162075 crossref_primary_10_1155_2023_7680659 crossref_primary_10_3390_ijms20020241 crossref_primary_10_1167_jov_23_6_13 crossref_primary_10_1167_iovs_18_24426 crossref_primary_10_26599_JNR_2019_9040003 crossref_primary_10_1007_s11095_018_2534_y crossref_primary_10_1007_s40266_020_00822_6 crossref_primary_10_1016_j_bbrc_2021_03_012 crossref_primary_10_1360_SSV_2021_0092 crossref_primary_10_1186_s13287_023_03434_0 crossref_primary_10_1016_j_jneumeth_2019_108442 crossref_primary_10_1186_s12967_024_05769_5 crossref_primary_10_1186_s13287_025_04196_7 crossref_primary_10_1016_j_gendis_2021_02_009 crossref_primary_10_1016_j_drudis_2018_12_004 crossref_primary_10_1002_stem_3239 crossref_primary_10_3390_genes9120575 crossref_primary_10_4252_wjsc_v13_i10_1446 crossref_primary_10_1016_j_preteyeres_2021_101038 crossref_primary_10_1038_s41598_020_79651_x crossref_primary_10_3390_pharmaceutics13060855 crossref_primary_10_1186_s12967_022_03738_4 crossref_primary_10_3389_fopht_2024_1377098 crossref_primary_10_1007_s11548_020_02160_9 crossref_primary_10_1097_APO_0000000000000538 crossref_primary_10_1111_cpr_12995 crossref_primary_10_2174_1574888X15666191218094020 crossref_primary_10_1007_s10384_022_00974_5 crossref_primary_10_1016_j_medj_2021_10_001 crossref_primary_10_1097_ICU_0000000000000657 crossref_primary_10_1038_s41596_023_00898_5 crossref_primary_10_1016_j_cmet_2021_03_021 crossref_primary_10_1186_s13287_023_03282_y crossref_primary_10_3390_pharmaceutics13060865 crossref_primary_10_3390_ijms22063237 crossref_primary_10_1016_j_reth_2024_11_010 crossref_primary_10_3390_cells12131689 crossref_primary_10_3389_fmed_2023_1125892 crossref_primary_10_1016_j_exer_2020_107950 crossref_primary_10_1039_D0ME00062K crossref_primary_10_1080_01658107_2019_1599027 crossref_primary_10_1242_dev_202067 crossref_primary_10_1038_s41598_019_47123_6 crossref_primary_10_1371_journal_pone_0227641 crossref_primary_10_1016_j_biomaterials_2020_120233 crossref_primary_10_1167_iovs_62_13_8 crossref_primary_10_1016_j_oret_2019_04_021 crossref_primary_10_1097_APO_0000000000000521 crossref_primary_10_1016_j_aopr_2024_02_001 crossref_primary_10_3390_molecules25245809 crossref_primary_10_1016_j_survophthal_2024_05_002 crossref_primary_10_1038_s41598_024_60895_w crossref_primary_10_1089_ten_teb_2021_0147 crossref_primary_10_1016_j_molmed_2021_01_001 crossref_primary_10_1002_sct3_13035 crossref_primary_10_1111_cpr_13785 crossref_primary_10_1016_j_jcyt_2024_02_022 crossref_primary_10_2174_1574888X17666220621153508 crossref_primary_10_1038_s41598_022_19777_2 crossref_primary_10_1177_2515841418817490 crossref_primary_10_1038_s41598_019_55130_w crossref_primary_10_3390_jcm9072217 crossref_primary_10_1038_s41598_020_58296_w crossref_primary_10_2174_0125899775250144230920053548 crossref_primary_10_1038_s41536_020_00100_4 crossref_primary_10_1016_j_preteyeres_2019_100779 crossref_primary_10_3390_cells10040859 crossref_primary_10_1016_j_molmed_2022_03_001 crossref_primary_10_3390_pharmaceutics16101299 crossref_primary_10_23950_jcmk_12502 crossref_primary_10_1186_s13287_022_03073_x crossref_primary_10_3389_fnins_2019_00471 crossref_primary_10_3390_ijms23020682 crossref_primary_10_1097_IAE_0000000000003273 crossref_primary_10_2217_rme_2021_0059 crossref_primary_10_1364_BOE_384919 crossref_primary_10_2139_ssrn_4170601 crossref_primary_10_3390_cells10112951 crossref_primary_10_1080_09286586_2021_1883675 crossref_primary_10_3389_fsurg_2022_888956 crossref_primary_10_1038_d41586_018_03268_4 crossref_primary_10_1177_20417314211059876 crossref_primary_10_4103_1673_5374_369121 crossref_primary_10_1109_MPULS_2019_2899702 crossref_primary_10_1080_13816810_2024_2423784 crossref_primary_10_1364_BOE_501743 crossref_primary_10_1038_s41556_019_0344_z crossref_primary_10_2174_1574888X16666210622124555 crossref_primary_10_3390_ijms21124273 crossref_primary_10_26599_JNR_2020_9040009 crossref_primary_10_3389_fcell_2021_737242 crossref_primary_10_1038_s41433_020_01286_z crossref_primary_10_1002_adhm_202202114 crossref_primary_10_1007_s12015_024_10802_7 crossref_primary_10_1038_s41598_020_80267_4 crossref_primary_10_1016_j_stem_2020_10_014 crossref_primary_10_1186_s13036_024_00405_8 crossref_primary_10_1016_j_stemcr_2020_02_006 crossref_primary_10_1038_s42003_019_0406_6 crossref_primary_10_34133_2020_1658678 crossref_primary_10_1113_JP284739 crossref_primary_10_3389_fcell_2022_910040 crossref_primary_10_3390_pharmaceutics12020176 crossref_primary_10_1016_j_pharmthera_2021_107976 crossref_primary_10_1016_j_semcdb_2022_09_011 crossref_primary_10_1186_s13287_021_02685_z crossref_primary_10_1371_journal_pgen_1009628 crossref_primary_10_4103_1673_5374_361537 crossref_primary_10_1186_s12967_023_04501_z crossref_primary_10_1073_pnas_2117553119 crossref_primary_10_3390_bioengineering12030278 |
Cites_doi | 10.1016/j.stem.2009.07.002 10.1056/NEJMoa1608368 10.1007/s00417-009-1201-8 10.3390/jcm3041302 10.1016/j.febslet.2006.03.083 10.1089/clo.2006.8.189 10.1016/j.ajo.2011.06.007 10.1016/S0140-6736(12)60118-4 10.1177/112067219900900310 10.1002/stem.149 10.1167/iovs.03-1034 10.1056/NEJMoa054481 10.1167/iovs.04-0193 10.1016/j.mam.2012.04.005 10.1111/j.1442-9071.2009.01915.x 10.1167/iovs.08-2845 10.1016/j.ophtha.2013.10.008 10.1016/S0161-6420(02)01099-0 10.1007/978-1-62703-080-9_20 10.1016/j.expneurol.2008.09.007 10.1038/s41598-017-00142-7 10.1089/clo.2004.6.217 10.1016/j.preteyeres.2015.06.004 10.1111/j.1442-9071.2007.01528.x 10.1167/iovs.07-0992 10.1016/j.tins.2013.03.006 10.1111/jphp.12362 10.1093/hmg/ddm074 10.1016/S0140-6736(14)61376-3 10.1016/j.ophtha.2004.07.023 10.1016/S0002-9394(02)01641-0 10.1038/sj.clpt.6100321 10.1167/iovs.12-11239 10.1167/iovs.13-13481 10.1007/978-3-540-71994-6 10.1097/IAE.0000000000001945 |
ContentType | Journal Article |
Copyright | Springer Nature America, Inc. 2018 COPYRIGHT 2018 Nature Publishing Group Copyright Nature Publishing Group Apr 2018 |
Copyright_xml | – notice: Springer Nature America, Inc. 2018 – notice: COPYRIGHT 2018 Nature Publishing Group – notice: Copyright Nature Publishing Group Apr 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM N95 IOV ISR 3V. 7QO 7QP 7QR 7T7 7TK 7TM 7X7 7XB 88A 88E 88I 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8G5 ABJCF ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. L6V LK8 M0S M1P M2O M2P M7P M7S MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS Q9U RC3 7X8 |
DOI | 10.1038/nbt.4114 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale Business: Insights Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection Biological Sciences ProQuest Health & Medical Collection Medical Database ProQuest Research Library Science Database Biological Science Database Engineering Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection ProQuest Central Basic Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Central Basic ProQuest Science Journals ProQuest SciTech Collection ProQuest Medical Library Materials Science & Engineering Collection ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Research Library Prep MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Engineering Agriculture Biology |
EISSN | 1546-1696 |
EndPage | 337 |
ExternalDocumentID | A533445024 29553577 10_1038_nbt_4114 |
Genre | Research Support, Non-U.S. Gov't Journal Article Clinical Trial, Phase I |
GrantInformation_xml | – fundername: Medical Research Council grantid: G1000730 |
GroupedDBID | --- -~X .55 .GJ 0R~ 123 29M 2FS 2XV 36B 39C 3V. 4.4 4R4 53G 5BI 5M7 5RE 5S5 70F 7X7 88A 88E 88I 8AO 8CJ 8FE 8FG 8FH 8FI 8FJ 8G5 8R4 8R5 A8Z AAEEF AAHBH AAIKC AAMNW AARCD AAYOK AAYZH AAZLF ABAWZ ABDBF ABDPE ABEFU ABJCF ABJNI ABLJU ABOCM ABUWG ACBTR ACBWK ACGFO ACGFS ACGOD ACIWK ACMJI ACPRK ACUHS ADBBV ADFRT AENEX AEUYN AFANA AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC BAAKF BBNVY BENPR BGLVJ BHPHI BKKNO BKOMP BPHCQ BVXVI C0K CCPQU D1J DB5 DU5 DWQXO EAD EAP EAS EBC EBS EE. EJD EMB EMK EMOBN ESX EXGXG F5P FA8 FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HVGLF HZ~ IAG IAO IEA IEP IH2 IHR INH INR IOV ISR ITC KOO L6V LGEZI LK8 LOTEE M0L M1P M2O M2P M7P M7S ML0 MVM N95 NADUK NEJ NNMJJ NXXTH O9- ODYON P2P PKN PQQKQ PROAC PSQYO PTHSS Q2X QF4 QM4 QN7 QO4 RNS RNT RNTTT RVV RXW SHXYY SIXXV SJN SNYQT SOJ SV3 TAE TAOOD TBHMF TDRGL TN5 TSG TUS U5U UKHRP X7M XI7 XOL Y6R YZZ ZGI ZHY ZXP ~KM AAYXX ACMFV ALPWD ATHPR CITATION PHGZM PHGZT ABFSG ACSTC AEZWR AFHIU AHWEU AIXLP CGR CUY CVF ECM EIF NFIDA NPM PJZUB PPXIY PQGLB PMFND 7QO 7QP 7QR 7T7 7TK 7TM 7XB 8FD 8FK C1K FR3 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 7X8 |
ID | FETCH-LOGICAL-c583t-a1372e8a4ea77bbdf8267c62f381460434028079daee476ca40a1dc4e35bc6c53 |
IEDL.DBID | 7X7 |
ISSN | 1087-0156 1546-1696 |
IngestDate | Fri Jul 11 11:03:47 EDT 2025 Sat Aug 23 13:01:41 EDT 2025 Tue Jun 17 20:43:34 EDT 2025 Tue Jun 10 20:43:43 EDT 2025 Fri Jun 27 05:00:19 EDT 2025 Fri Jun 27 04:39:11 EDT 2025 Fri Jun 27 03:05:28 EDT 2025 Mon Jul 21 06:05:43 EDT 2025 Tue Jul 01 04:09:57 EDT 2025 Thu Apr 24 23:13:05 EDT 2025 Fri Feb 21 02:39:40 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c583t-a1372e8a4ea77bbdf8267c62f381460434028079daee476ca40a1dc4e35bc6c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5469-0030 |
PMID | 29553577 |
PQID | 2021769847 |
PQPubID | 47191 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2015410490 proquest_journals_2021769847 gale_infotracmisc_A533445024 gale_infotracacademiconefile_A533445024 gale_incontextgauss_ISR_A533445024 gale_incontextgauss_IOV_A533445024 gale_businessinsightsgauss_A533445024 pubmed_primary_29553577 crossref_citationtrail_10_1038_nbt_4114 crossref_primary_10_1038_nbt_4114 springer_journals_10_1038_nbt_4114 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-01 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationSubtitle | The Science and Business of Biotechnology |
PublicationTitle | Nature biotechnology |
PublicationTitleAbbrev | Nat Biotechnol |
PublicationTitleAlternate | Nat Biotechnol |
PublicationYear | 2018 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | Atala (CR1) 2012; 379 Lu (CR32) 2009; 27 Nazari (CR3) 2015; 48 Rosenfeld (CR6) 2006; 355 Idelson (CR14) 2009; 5 Chen (CR26) 2009; 37 Wang (CR31) 2008; 49 CR19 Hewitt, Amps, Moore (CR35) 2007; 82 Bressler (CR20) 2004; 111 CR12 Schwartz (CR8) 2015; 385 Algvere, Gouras, Dafgard Kopp (CR30) 1999; 9 Carr (CR36) 2009; 15 Amer, White, Shakesheff (CR21) 2015; 67 Cereda, Parolini, Bellesini, Pertile (CR28) 2010; 248 Chen (CR34) 2009; 50 Mao, Finnemann (CR37) 2013; 935 Klimanskaya (CR13) 2004; 6 Lund (CR17) 2006; 8 Carr (CR2) 2013; 36 Vugler (CR10) 2008; 214 Pertile, Claes (CR33) 2002; 134 Haruta (CR11) 2004; 45 van Zeeburg, Maaijwee, Missotten, Heimann, van Meurs (CR25) 2012; 153 Stanga (CR24) 2002; 109 Bhutto, Lutty (CR5) 2012; 33 Tezel, Del Priore, Kaplan (CR22) 2004; 45 Diniz (CR23) 2013; 54 Allegrucci (CR16) 2007; 16 Bharti (CR4) 2014; 55 Skottman, Dilber, Hovatta (CR15) 2006; 580 CR27 Mandai (CR9) 2017; 376 Muthiah (CR7) 2014; 121 Sparrow, Duncker (CR18) 2014; 3 Ramsden (CR38) 2017; 7 Uppal (CR29) 2007; 35 BFnbt4114_CR12 PV Algvere (BFnbt4114_CR30) 1999; 9 MN Muthiah (BFnbt4114_CR7) 2014; 121 FK Chen (BFnbt4114_CR34) 2009; 50 BFnbt4114_CR19 JR Sparrow (BFnbt4114_CR18) 2014; 3 RD Lund (BFnbt4114_CR17) 2006; 8 AJ Carr (BFnbt4114_CR2) 2013; 36 G Pertile (BFnbt4114_CR33) 2002; 134 MG Cereda (BFnbt4114_CR28) 2010; 248 PJ Rosenfeld (BFnbt4114_CR6) 2006; 355 CM Ramsden (BFnbt4114_CR38) 2017; 7 M Haruta (BFnbt4114_CR11) 2004; 45 NM Bressler (BFnbt4114_CR20) 2004; 111 I Klimanskaya (BFnbt4114_CR13) 2004; 6 M Mandai (BFnbt4114_CR9) 2017; 376 Y Mao (BFnbt4114_CR37) 2013; 935 B Lu (BFnbt4114_CR32) 2009; 27 AJ Carr (BFnbt4114_CR36) 2009; 15 H Skottman (BFnbt4114_CR15) 2006; 580 MH Amer (BFnbt4114_CR21) 2015; 67 TH Tezel (BFnbt4114_CR22) 2004; 45 BFnbt4114_CR27 A Atala (BFnbt4114_CR1) 2012; 379 I Bhutto (BFnbt4114_CR5) 2012; 33 EJ van Zeeburg (BFnbt4114_CR25) 2012; 153 H Nazari (BFnbt4114_CR3) 2015; 48 B Diniz (BFnbt4114_CR23) 2013; 54 S Wang (BFnbt4114_CR31) 2008; 49 M Idelson (BFnbt4114_CR14) 2009; 5 C Allegrucci (BFnbt4114_CR16) 2007; 16 K Bharti (BFnbt4114_CR4) 2014; 55 FK Chen (BFnbt4114_CR26) 2009; 37 PE Stanga (BFnbt4114_CR24) 2002; 109 A Vugler (BFnbt4114_CR10) 2008; 214 G Uppal (BFnbt4114_CR29) 2007; 35 SD Schwartz (BFnbt4114_CR8) 2015; 385 ZA Hewitt (BFnbt4114_CR35) 2007; 82 29691492 - Nat Rev Neurol. 2018 Jun;14(6):317. doi: 10.1038/s41582-018-0007-x. |
References_xml | – volume: 5 start-page: 396 year: 2009 end-page: 408 ident: CR14 article-title: Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells publication-title: Cell Stem Cell doi: 10.1016/j.stem.2009.07.002 – volume: 376 start-page: 1038 year: 2017 end-page: 1046 ident: CR9 article-title: Autologous induced stem-cell-derived retinal cells for macular degeneration publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1608368 – volume: 248 start-page: 37 year: 2010 end-page: 47 ident: CR28 article-title: Surgery for CNV and autologous choroidal RPE patch transplantation: exposing the submacular space publication-title: Graefes Arch. Clin. Exp. Ophthalmol. doi: 10.1007/s00417-009-1201-8 – volume: 3 start-page: 1302 year: 2014 end-page: 1321 ident: CR18 article-title: Fundus autofluorescence and RPE lipofuscin in age-related macular degeneration publication-title: J. Clin. Med. doi: 10.3390/jcm3041302 – volume: 15 start-page: 283 year: 2009 end-page: 295 ident: CR36 article-title: Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay publication-title: Mol. Vis. – volume: 580 start-page: 2875 year: 2006 end-page: 2878 ident: CR15 article-title: The derivation of clinical-grade human embryonic stem cell lines publication-title: FEBS Lett. doi: 10.1016/j.febslet.2006.03.083 – ident: CR12 – volume: 8 start-page: 189 year: 2006 end-page: 199 ident: CR17 article-title: Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats publication-title: Cloning Stem Cells doi: 10.1089/clo.2006.8.189 – volume: 153 start-page: 120 year: 2012 end-page: 7 ident: CR25 article-title: A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years publication-title: Am. J. Ophthalmol. doi: 10.1016/j.ajo.2011.06.007 – volume: 379 start-page: 689 year: 2012 end-page: 690 ident: CR1 article-title: Human embryonic stem cells: early hints on safety and efficacy publication-title: Lancet doi: 10.1016/S0140-6736(12)60118-4 – volume: 9 start-page: 217 year: 1999 end-page: 30 ident: CR30 article-title: Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD publication-title: Eur. J. Ophthalmol. doi: 10.1177/112067219900900310 – volume: 27 start-page: 2126 year: 2009 end-page: 2135 ident: CR32 article-title: Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration publication-title: Stem Cells doi: 10.1002/stem.149 – volume: 45 start-page: 1020 year: 2004 end-page: 1025 ident: CR11 article-title: In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.03-1034 – volume: 355 start-page: 1419 year: 2006 end-page: 1431 ident: CR6 article-title: Ranibizumab for neovascular age-related macular degeneration publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa054481 – ident: CR27 – volume: 45 start-page: 3337 year: 2004 end-page: 3348 ident: CR22 article-title: Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.04-0193 – volume: 33 start-page: 295 year: 2012 end-page: 317 ident: CR5 article-title: Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex publication-title: Mol. Aspects Med. doi: 10.1016/j.mam.2012.04.005 – volume: 37 start-page: 275 year: 2009 end-page: 285 ident: CR26 article-title: Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration publication-title: Clin. Experiment. Ophthalmol. doi: 10.1111/j.1442-9071.2009.01915.x – volume: 50 start-page: 1848 year: 2009 end-page: 1855 ident: CR34 article-title: A comparison of macular translocation with patch graft in neovascular age-related macular degeneration publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.08-2845 – ident: CR19 – volume: 121 start-page: 430 year: 2014 end-page: 431.e3 ident: CR7 article-title: Adaptive optics imaging shows rescue of macula cone photoreceptors publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.10.008 – volume: 109 start-page: 1492 year: 2002 end-page: 1498 ident: CR24 article-title: Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01099-0 – volume: 935 start-page: 285 year: 2013 end-page: 295 ident: CR37 article-title: Analysis of photoreceptor outer segment phagocytosis by RPE cells in culture publication-title: Methods Mol. Biol. doi: 10.1007/978-1-62703-080-9_20 – volume: 214 start-page: 347 year: 2008 end-page: 361 ident: CR10 article-title: Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2008.09.007 – volume: 7 start-page: 51 year: 2017 ident: CR38 article-title: Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs publication-title: Sci. Rep. doi: 10.1038/s41598-017-00142-7 – volume: 6 start-page: 217 year: 2004 end-page: 245 ident: CR13 article-title: Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics publication-title: Cloning Stem Cells doi: 10.1089/clo.2004.6.217 – volume: 48 start-page: 1 year: 2015 end-page: 39 ident: CR3 article-title: Stem cell based therapies for age-related macular degeneration: The promises and the challenges publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2015.06.004 – volume: 35 start-page: 448 year: 2007 end-page: 457 ident: CR29 article-title: New algorithm for assessing patient suitability for macular translocation surgery publication-title: Clin. Experiment. Ophthalmol. doi: 10.1111/j.1442-9071.2007.01528.x – volume: 49 start-page: 416 year: 2008 end-page: 421 ident: CR31 article-title: Morphological and functional rescue in RCS rats after RPE cell line transplantation at a later stage of degeneration publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.07-0992 – volume: 36 start-page: 385 year: 2013 end-page: 395 ident: CR2 article-title: Development of human embryonic stem cell therapies for age-related macular degeneration publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.03.006 – volume: 67 start-page: 640 year: 2015 end-page: 650 ident: CR21 article-title: The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies publication-title: J. Pharm. Pharmacol. doi: 10.1111/jphp.12362 – volume: 16 start-page: 1253 year: 2007 end-page: 1268 ident: CR16 article-title: Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm074 – volume: 385 start-page: 509 year: 2015 end-page: 516 ident: CR8 article-title: Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies publication-title: Lancet doi: 10.1016/S0140-6736(14)61376-3 – volume: 111 start-page: 1993 year: 2004 end-page: 2006 ident: CR20 article-title: Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.07.023 – volume: 134 start-page: 560 year: 2002 end-page: 565 ident: CR33 article-title: Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization publication-title: Am. J. Ophthalmol. doi: 10.1016/S0002-9394(02)01641-0 – volume: 82 start-page: 448 year: 2007 end-page: 452 ident: CR35 article-title: Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application publication-title: Clin. Pharmacol. Ther. doi: 10.1038/sj.clpt.6100321 – volume: 54 start-page: 5087 year: 2013 end-page: 5096 ident: CR23 article-title: Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.12-11239 – volume: 55 start-page: 1191 year: 2014 end-page: 1202 ident: CR4 article-title: Developing cellular therapies for retinal degenerative diseases publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.13-13481 – volume: 48 start-page: 1 year: 2015 ident: BFnbt4114_CR3 publication-title: Prog. Retin. Eye Res. doi: 10.1016/j.preteyeres.2015.06.004 – volume: 5 start-page: 396 year: 2009 ident: BFnbt4114_CR14 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2009.07.002 – volume: 16 start-page: 1253 year: 2007 ident: BFnbt4114_CR16 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddm074 – ident: BFnbt4114_CR19 doi: 10.1007/978-3-540-71994-6 – volume: 3 start-page: 1302 year: 2014 ident: BFnbt4114_CR18 publication-title: J. Clin. Med. doi: 10.3390/jcm3041302 – volume: 580 start-page: 2875 year: 2006 ident: BFnbt4114_CR15 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2006.03.083 – volume: 8 start-page: 189 year: 2006 ident: BFnbt4114_CR17 publication-title: Cloning Stem Cells doi: 10.1089/clo.2006.8.189 – volume: 49 start-page: 416 year: 2008 ident: BFnbt4114_CR31 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.07-0992 – volume: 45 start-page: 3337 year: 2004 ident: BFnbt4114_CR22 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.04-0193 – volume: 9 start-page: 217 year: 1999 ident: BFnbt4114_CR30 publication-title: Eur. J. Ophthalmol. doi: 10.1177/112067219900900310 – volume: 379 start-page: 689 year: 2012 ident: BFnbt4114_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(12)60118-4 – volume: 935 start-page: 285 year: 2013 ident: BFnbt4114_CR37 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-62703-080-9_20 – volume: 37 start-page: 275 year: 2009 ident: BFnbt4114_CR26 publication-title: Clin. Experiment. Ophthalmol. doi: 10.1111/j.1442-9071.2009.01915.x – volume: 109 start-page: 1492 year: 2002 ident: BFnbt4114_CR24 publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01099-0 – volume: 82 start-page: 448 year: 2007 ident: BFnbt4114_CR35 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/sj.clpt.6100321 – volume: 45 start-page: 1020 year: 2004 ident: BFnbt4114_CR11 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.03-1034 – volume: 33 start-page: 295 year: 2012 ident: BFnbt4114_CR5 publication-title: Mol. Aspects Med. doi: 10.1016/j.mam.2012.04.005 – volume: 54 start-page: 5087 year: 2013 ident: BFnbt4114_CR23 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.12-11239 – volume: 121 start-page: 430 year: 2014 ident: BFnbt4114_CR7 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.10.008 – volume: 36 start-page: 385 year: 2013 ident: BFnbt4114_CR2 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.03.006 – volume: 55 start-page: 1191 year: 2014 ident: BFnbt4114_CR4 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.13-13481 – ident: BFnbt4114_CR27 doi: 10.1097/IAE.0000000000001945 – volume: 376 start-page: 1038 year: 2017 ident: BFnbt4114_CR9 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1608368 – volume: 27 start-page: 2126 year: 2009 ident: BFnbt4114_CR32 publication-title: Stem Cells doi: 10.1002/stem.149 – ident: BFnbt4114_CR12 – volume: 355 start-page: 1419 year: 2006 ident: BFnbt4114_CR6 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa054481 – volume: 385 start-page: 509 year: 2015 ident: BFnbt4114_CR8 publication-title: Lancet doi: 10.1016/S0140-6736(14)61376-3 – volume: 111 start-page: 1993 year: 2004 ident: BFnbt4114_CR20 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.07.023 – volume: 50 start-page: 1848 year: 2009 ident: BFnbt4114_CR34 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.08-2845 – volume: 134 start-page: 560 year: 2002 ident: BFnbt4114_CR33 publication-title: Am. J. Ophthalmol. doi: 10.1016/S0002-9394(02)01641-0 – volume: 6 start-page: 217 year: 2004 ident: BFnbt4114_CR13 publication-title: Cloning Stem Cells doi: 10.1089/clo.2004.6.217 – volume: 248 start-page: 37 year: 2010 ident: BFnbt4114_CR28 publication-title: Graefes Arch. Clin. Exp. Ophthalmol. doi: 10.1007/s00417-009-1201-8 – volume: 67 start-page: 640 year: 2015 ident: BFnbt4114_CR21 publication-title: J. Pharm. Pharmacol. doi: 10.1111/jphp.12362 – volume: 214 start-page: 347 year: 2008 ident: BFnbt4114_CR10 publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2008.09.007 – volume: 153 start-page: 120 year: 2012 ident: BFnbt4114_CR25 publication-title: Am. J. Ophthalmol. doi: 10.1016/j.ajo.2011.06.007 – volume: 35 start-page: 448 year: 2007 ident: BFnbt4114_CR29 publication-title: Clin. Experiment. Ophthalmol. doi: 10.1111/j.1442-9071.2007.01528.x – volume: 7 start-page: 51 year: 2017 ident: BFnbt4114_CR38 publication-title: Sci. Rep. doi: 10.1038/s41598-017-00142-7 – volume: 15 start-page: 283 year: 2009 ident: BFnbt4114_CR36 publication-title: Mol. Vis. – reference: 29691492 - Nat Rev Neurol. 2018 Jun;14(6):317. doi: 10.1038/s41582-018-0007-x. |
SSID | ssj0006466 |
Score | 2.681734 |
Snippet | An engineered patch of retinal pigment epithelium generated from human embryonic stem cells is transplanted into the eyes of two patients.
Age-related macular... Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 328 |
SubjectTerms | 13 13/1 14 14/63 59 631/61/490 692/308/2171 Acuity Age Age related diseases Aged Agriculture Animals Basement Membrane - diagnostic imaging Basement Membrane - growth & development Bioinformatics Biomedical Engineering/Biotechnology Biomedicine Biotechnology Blindness Care and treatment Cell Differentiation - genetics Embryonic stem cells Epithelium Feasibility studies Female Health aspects Human Embryonic Stem Cells - transplantation Humans Immunosuppression Life Sciences Macular degeneration Macular Degeneration - diagnostic imaging Macular Degeneration - pathology Macular Degeneration - therapy Male Methods Mice Middle Aged Optical Coherence Tomography Patients Retina Retinal pigment epithelium Retinal Pigment Epithelium - diagnostic imaging Retinal Pigment Epithelium - growth & development Retinal Pigment Epithelium - transplantation Safety Stem cell transplantation Stem Cell Transplantation - adverse effects Stem cells Surgical instruments Swine Tomography, Optical Coherence Transplantation Tumorigenicity Visual acuity Visual Acuity - physiology |
Title | Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration |
URI | https://link.springer.com/article/10.1038/nbt.4114 https://www.ncbi.nlm.nih.gov/pubmed/29553577 https://www.proquest.com/docview/2021769847 https://www.proquest.com/docview/2015410490 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagFQgOCJbXQqlMBeopJdnYsXNCBXUpSC1VoWhvkeNMtit1k9DsIvXAf2cmcbbNCiEuueRLHHucsT2Pbxh7Y4UQORC_HRhyM8rYSwOZe-AL8K22MeSU73x0HB2eiS8TOXEGt9qFVXY6sVHUWWnJRk6H9EBFMSrT99VPj6pGkXfVldC4zTaJuoxmtZqsDly42ja-ysDXFF4po458NtTvinSxJ4JA9JajdaV8Y1Vac5M2q8_4IXvgto18v5XzI3YLigG70xaSvBqw-zdoBQfs7pFzmD9mv0_OcZniAe8yIHnDJ8vLnJuCwzy9vCJuXE50zpyM-F6GL_kFGafsRmqymk3JgMihouyNi9lyzitU3-d8VnDURV6TDIP4uWkiWnkG04bJmgT-hJ2ND75_PPRcxQXPSh0uPBOEagTaCDBKpWmW4-FD2WiUh2Qp9EUoyBOr4swACBVZI3wTZFZAKFMbWRk-ZRtFWcBzxo3UVihI09CCACtjgTtPlYo8srnUOh6y3W7gE-voyKkqxkXSuMVDnaCIEhLRkL1eIauWguMvmLcku8RV7sRLTbaNemqWdZ3sU74xtj9C3E6DI-aLgkJrWsDnrz_-A_TttAfadaC8xO-2xqUzYO-JUauH3Ooh8f-1_dvdfEuc_qiT69mOvV_dpicpJq6AckkY3P4G5LkdsmftPF2NzyiWMpQKn97pJu71y9cH78W_v-Alu4dN6TZcaYttLC6X8Ap3Yot0u_nd8KrHn7bZ5oeD45PTP5xXNEI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRbwOCMIrUGCpqHoy-LHrtQ8IVUBIaFMQtFVvZr0ep5Ea29QJKAf-Er-RGT_SJkKISy---LPX3p2d2d2Z-YaxF0YIkQLx24EmN6MMrdiRqQW2ANsEJoSU8p2H-37_UHw8lsdr7HebC0Nhla1OrBR1khs6I6dNuqP8EJXpm-K7RVWjyLvaltCoxWIX5j9xy1a-HrzD8d1y3d77g7d9q6kqYBkZeFNLO55yIdACtFJxnKS4wFbGd1OPTsNs4QnyNqow0QBC-UYLWzuJEeDJ2PiGqkSgyr8iPLTklJne-7DQ_H7tG3XsgMI5pd-S3XrBqyyevhSOI5bM36oRuGAFV9yylbXr3Wa3mmUq36nl6g5bg6zDrtaFK-cddvMCjWGHXRs2Dvq77NfnEzSL3OFtxiWv-Gt5nnKdcZjEZ3Pi4uVEH83JaWAl-JIfkHDKpqQmi_GIDiw5FJQtcjqeTXiB5uKEjzOOus-qkm8QP9FVBC1PYFQxZ5OA3WOHlzIW99l6lmfwkHEtAyMUxLFnQICRocCVropF6ptUBkHYZdttx0emoT-nKhynUeWG94IIhyiiIeqy5wtkUVN-_AWzRWMXNZVC8VLSWUo50rOyjHYovxnbdxG3WeGIaSOjUJ4aMPh09B-gr1-WQNsNKM3xu41u0ifw74nBawm5sYREfWGWb7fyFjX6qozOZxf-_eI2PUkxeBnkM8LgctshT3GXPajldNE_biilJxU-vdkK7vnLVzvv0b-_4Bm73j8Y7kV7g_3dx-wGNhvUoVIbbH16NoMnuAqcxk-rqcfZt8ue638Az1huXA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VqajoAUF4pRRYKqqeTP3Y9doHhApt1FAaokKr3sx6PU4jNU6oE1AO_DF-HTN-pE2EEJdefPFnr707O7O7M_MNY6-NECIF4rcDTW5GGVqxI1MLbAG2CUwIKeU7H3f9w1Px8Vyer7DfdS4MhVXWOrFQ1MnI0Bk5bdId5YeoTHfTKiyit99-N_5uUQUp8rTW5TRKETmC2U_cvuVvO_s41tuu2z74-uHQqioMWEYG3sTSjqdcCLQArVQcJykutpXx3dSjkzFbeII8jypMNIBQvtHC1k5iBHgyNr6hihGo_lcV7YoabPX9Qbd3MrcDfukpdeyAgjulX1PfesFuFk_eCMcRC8Zw2STcsIlLTtrC9rXvs3vVopXvlVL2gK1A1mR3yjKWsyZbv0Fq2GRrx5W7_iH71btAI8kdXudf8oLNlo9SrjMOw_hqRsy8nMikObkQrARf8gMSTrmV1OR40KfjSw5jyh25HEyHfIzG44IPMo6a0CpScRA_1EU8LU-gX_Bok7g9Yqe3MhqPWSMbZfCUcS0DIxTEsWdAgJGhwHWvikXqm1QGQdhiO3XHR6YiQ6eaHJdR4ZT3ggiHKKIharFXc-S4JAD5C2abxi6q6obiJaeTlbyvp3ke7VG2M7bvIm6rwBHvRkYSXAI6n8_-A_TlZAG0U4HSEX630VUyBf498XktIDcXkKg9zOLtWt6iSnvl0fVcw7-f36YnKSIvg9GUMLj4dshv3GJPSjmd948bSulJhU9v1YJ7_fLlztv49xe8ZGs4z6NPne7RM3YXWw3KuKlN1phcTeE5Lgkn8Ytq7nH27ban-x8ZU3Pu |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+1+clinical+study+of+an+embryonic+stem+cell-derived+retinal+pigment+epithelium+patch+in+age-related+macular+degeneration&rft.jtitle=Nature+biotechnology&rft.au=da+Cruz%2C+Lyndon&rft.au=Fynes%2C+Kate&rft.au=Georgiadis%2C+Odysseas&rft.au=Kerby%2C+Julie&rft.date=2018-04-01&rft.pub=Nature+Publishing+Group&rft.issn=1087-0156&rft.volume=36&rft.issue=4&rft.spage=328&rft_id=info:doi/10.1038%2Fnbt.4114&rft.externalDBID=N95&rft.externalDocID=A533445024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1087-0156&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1087-0156&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1087-0156&client=summon |